🎉We're thrilled to extend a warm ALAMAR welcome to Dr. Cheryl Wellington and her team at the The University of British Columbia! They've just completed their training to implement #NULISA and the #ARGO HT technology into their facility, making it our first-ever instrument in Canada. This collaboration will pave the way for groundbreaking research in high-sensitivity, multiplex detection of neurodegenerative protein biomarkers. We can't wait to see the incredible work that will emerge from this partnership! Learn more about how the ARGO HT System can advance your protein biomarker analysis 👉 https://ow.ly/rQsc50T1oaY
Alamar Biosciences, Inc.
Biotechnology Research
Fremont, California 12,595 followers
Powering Precision Proteomics with unrivaled sensitivity and simplicity
About us
Alamar Biosciences is powering precision proteomics with automated, high throughput solutions for ultra-high sensitivity protein analysis across a range of multiplex levels. Our proprietary NULISA™ Chemistry utilizes a novel sequential capture and release method that significantly reduces background signal and increases the sensitivity and dynamic range compared with standard approaches and allows both qPCR and NGS readouts. The NULISAseq Inflammation Panel contains 200 important markers related to immune and inflammatory diseases and will run on our ARGO™ System. This innovative platform allows for a fully automated workflow with less than 30 minutes hands on time from sample to data.
- Website
-
http://www.alamarbio.com
External link for Alamar Biosciences, Inc.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Fremont, California
- Type
- Privately Held
- Founded
- 2018
Locations
-
Primary
47071 Bayside Pkwy
Fremont, California 94538, US
Employees at Alamar Biosciences, Inc.
Updates
-
🚀🎙️ Exciting News in the World of Proteomics! 🎙️🚀 Dive into our new podcast series featured on the Mendelspod, as we explore how Alamar's groundbreaking technology is delivering unprecedented sensitivity and scale, transforming research in critical areas like Alzheimer’s and inflammatory diseases. First two episodes out now! 👉 https://ow.ly/3xeE50SU7MY
-
📣 Exciting News 📣 We’re thrilled to announce that Stanford University's Human Immune Monitoring Center is the first #ARGO HT #hero to be part of Alamar’s prestigious #ARGOnaut Club! Being selected as an ARGOnaut signifies being a hero in the field of #proteomics and at the forefront of innovation and excellence in the research community. Welcome Dr. Holden Maecker and team! We can’t wait to see the incredible advancements and insights this system and community will bring to the field of proteomics. To see the work this ARGOnaut team has already produced, check out their recent publication here: https://ow.ly/A7Cj50SQg63 Stay tuned as we announce more heroes of Alamar's ARGOnaut Club!
-
-
📣 Exciting news 📣 Alamar Biosciences is thrilled to announce the opening of our European headquarters and distribution center in Milan, Italy! This strategic expansion underscores our dedication to advancing global scientific research and supporting the commercialization of our cutting-edge ARGO HT System and NULISA Platform. Stay tuned for more updates as we continue to power precision proteomics and enable the earliest detection of disease. Read the full press release: https://ow.ly/K8gr50SOk1C
-
-
Happening TODAY! Don't miss our Product Theater at 12:25 pm in the Exhibit Hall featuring presentations from Amanda Heslegrave of UCL and Thomas KariKari, PhD of University of Pittsburgh and experience pTau and beyond, with the #NULISAseq CNS Disease Panel 120 for high sensitivity, multiplexed analysis of CNS disease biomarkers from biofluids. 🧠🔬 See you there! 👋
-
-
#AAIC2024 Day 2 was another excellent day for #proteomics in Alzheimer’s disease research. Six posters featuring #NULISA data were presented and lots of great inquiries and conversations were had in our booth and elsewhere. Don’t miss our product theater on Tuesday at 12:25 PM featuring presentations by leading researchers from UCL and University of Pittsburgh where comparative data on fluid biomarkers for Alzheimer’s disease will be discussed.
-
-
-
-
-
3
-
-
#AAIC2024 Day 1 was a busy and outstanding day for the latest advancements in #Alzheimer's disease research, detection, drug discovery and therapy! A big thank you to Dr. Xuemei Zeng and Dr. Thomas Karikari from University of Pittsburgh, and Dr. Zimren and Dr. Henrik Zetterberg from University of Gothenburg for presenting data on how #NULISA is making a positive impact in AD research. Alamar's booth was buzzing with interest and we look forward to meeting many more potential partners over the next few days. Stop by booth 936 to see what's new with the latest #proteomic detection for pTau and beyond! https://lnkd.in/gVjguPq8
-
-
-
-
-
4
-
-
Don't miss this featured talk at #AAIC2024 with Dr. Henrik Zetterberg from University of Gothenburg as he discusses the use of the #NULISA assay for Alzheimer's Disease and related dementias. TODAY, Sunday, July 28 at 4:30PM, in the Nutter theater. Come to booth 936 to learn more about pTau217 and beyond. https://lnkd.in/gVjguPq8
-
-
Attending #AAIC2024? Come chat with Christopher Bunker, Ph.D., M.B.A., Alex Forrest-Hay, Brad Nawa, Max Mahoney Yuling Luo,Xiao-Jun Ma, Anna Berdine, Daniel Frederick, Niyati Jhaveri, and Barry Lynch to learn more about ultra-sensitive, multiplex, blood-based #proteomics for pTau and beyond! Booth 936. #NULISA
-
#AAIC2024 is here! Explore groundbreaking research powered by the #NULISA Platform during several featured presentations and posters and discover how NULISA sets a new standard in protein biomarker analysis with attomolar sensitivity and high multiplexing. Stop by booth 936 to learn more or click the link to schedule a live demo of the #ARGO HT System with one of our experts. 👉 https://ow.ly/a1IF50SIKzw